Enrolling by invitationNCT06163508
A Long Term Follow-Up Study for Subjects Who Have Received Q-Cells
Studying OBSOLETE: Secondary acute transverse myelitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Texas Southwestern Medical Center
- Principal Investigator
- Benjamin Greenberg, MDUniversity of Texas Southwestern Medial Center
- Intervention
- Q-Cells®(drug)
- Enrollment
- 9 target
- Eligibility
- All sexes
- Timeline
- 2023 – 2035
Study locations (1)
- The University of Texas Southwestern Medical Center, Dallas, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06163508 on ClinicalTrials.govOther trials for OBSOLETE: Secondary acute transverse myelitis
Additional recruiting or active studies for the same condition.
See all trials for OBSOLETE: Secondary acute transverse myelitis →